KARABULUT, B. Et Al. 2009. Docetaxel/zoledronic acid combination triggers apoptosis synergistically through downregulating antiapoptotic Bcl-2 protein level in hormone-refractory prostate cancer cells. CELL BIOLOGY INTERNATIONAL , vol.33, no.2 , 239-246.

KARABULUT, B., Erten, C., Gul, M. K., Cengiz, E., KARACA, B., Kucukzeybek, Y., ... Gorumlu, G.(2009). Docetaxel/zoledronic acid combination triggers apoptosis synergistically through downregulating antiapoptotic Bcl-2 protein level in hormone-refractory prostate cancer cells. CELL BIOLOGY INTERNATIONAL , vol.33, no.2, 239-246.

KARABULUT, BÜLENT Et Al. "Docetaxel/zoledronic acid combination triggers apoptosis synergistically through downregulating antiapoptotic Bcl-2 protein level in hormone-refractory prostate cancer cells," CELL BIOLOGY INTERNATIONAL , vol.33, no.2, 239-246, 2009

KARABULUT, BÜLENT Et Al. "Docetaxel/zoledronic acid combination triggers apoptosis synergistically through downregulating antiapoptotic Bcl-2 protein level in hormone-refractory prostate cancer cells." CELL BIOLOGY INTERNATIONAL , vol.33, no.2, pp.239-246, 2009

KARABULUT, B. Et Al. (2009) . "Docetaxel/zoledronic acid combination triggers apoptosis synergistically through downregulating antiapoptotic Bcl-2 protein level in hormone-refractory prostate cancer cells." CELL BIOLOGY INTERNATIONAL , vol.33, no.2, pp.239-246.

@article{article, author={BÜLENT KARABULUT Et Al. }, title={Docetaxel/zoledronic acid combination triggers apoptosis synergistically through downregulating antiapoptotic Bcl-2 protein level in hormone-refractory prostate cancer cells}, journal={CELL BIOLOGY INTERNATIONAL}, year=2009, pages={239-246} }